|Bid||14.31 x 1100|
|Ask||14.63 x 1000|
|Day's Range||12.82 - 14.87|
|52 Week Range||1.60 - 35.10|
|Beta (5Y Monthly)||1.42|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jan 20, 2017|
|1y Target Est||N/A|
The big shareholder groups in Altimmune, Inc. ( NASDAQ:ALT ) have power over the company. Insiders often own a large...
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]
Altimmune, Inc. (NASDAQ:ALT) defied analyst predictions to release its third-quarter results, which were ahead of...